Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease…Ongoing

A Randomized, Placebo controlled, Double-Blind Clinical Trial to Study the Efficacy and Safety of MK-8931 in Subjects with Amnestic Mild Cognitive Impairment Due to Alzheimer’s Disease. (Prodromal AD)

This is an 18 month study in which subjects that screen and qualify will go onto the program taking the investigation medication by mouth once daily.

Eisai / Mild Cognitive Impairment or Mild Alzheimer’s Disease

Eisai / Mild Cognitive Impairment or Mild Alzheimer’s Disease…Ongoing Study

What is Mild Cognitive Impairment (MCI)?

Mild Cognitive Impairment is a condition in which a person has memory loss or thinking problems that are worse than those caused by normal aging, but not bad enough to interfere with daily activities.  A person with MCI has a higher risk of developing Alzheimer’s disease,

Forgetfulness or Something More Serious?

Forgetfulness or Something More Serious?

Older people often begin to notice a decline in their memory. But, they may not realize how much memory loss is “normal,” and what could be a sign of something more serious. We have outlined some symptoms that are likely signs of normal memory loss due to aging and provided a list of more serious symptoms.